Phase 2 Recruiting NIH
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
This phase II trial studies how well osimertinib works in treating patients with non-small cell lung cancer with EGFR exon 20 insertion mutation that is stage IIIB-IV or has come back after a period of improvement (recurrent). Osimertinib …
Sponsor: National Cancer Institute (NCI)
NCT ID: NCT03191149
Sites in Wyoming:
- Memorial Hospital of Laramie County — Cheyenne, Wyoming
- Billings Clinic-Cody — Cody, Wyoming
- Welch Cancer Center — Sheridan, Wyoming